Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 2.68% | $3.74M | $639.28B | 40.86% | 74 Outperform | |
| Chevron | 1.98% | $2.76M | $366.98B | 17.88% | 71 Outperform | |
| Johnson & Johnson | 1.86% | $2.59M | $574.26B | 53.70% | 78 Outperform | |
| HSBC Holdings | 1.38% | $1.92M | £224.31B | 48.12% | 80 Outperform | |
| Philip Morris | 1.35% | $1.89M | $284.39B | 21.31% | 61 Neutral | |
| AbbVie | 1.29% | $1.80M | $393.14B | 15.68% | 66 Neutral | |
| Merck & Company | 1.28% | $1.79M | $290.77B | 37.33% | 80 Outperform | |
| Altria Group | 1.27% | $1.78M | $108.11B | 20.73% | 64 Neutral | |
| PepsiCo | 1.17% | $1.63M | $228.19B | 15.61% | 78 Outperform | |
| Intesa Sanpaolo SpA | 1.10% | $1.53M | €105.06B | 36.83% | 76 Outperform |